Fig. 1
From: FGF23C-tail improves diabetic nephropathy by attenuating renal fibrosis and inflammation
FGF23C-tail treatment improved renal hypertrophy and dysfunction in db/db mice. a Treatment protocol for db/db mice wherein db/db mice received vehicle or FGF23C-tail (0.5Â mg/kg body weight (BW), every other day) for 12Â weeks; b Photograph of representative mice and kidneys of db/m, db/db, and FGF23C-tail group. c Kidney weight-to-body weight (KW/BW) ratio in db/m, db/db, and FGF23C-tail group; d Renal function was determined by measuring excretion of creatinine and e the level of BUN and f micro-albumin in urine; g The levels of FGF23 in serum; h the levels of phosphorous (Pi) in serum